Hans L Hillege Selected Research

Fosinopril (Monopril)

7/2008	Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
1/2008	Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects.
3/2006	Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
3/2005	Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria.
11/2004	Framingham score and microalbuminuria: combined future targets for primary prevention?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans L Hillege Research Topics

Disease

94	Heart Failure 01/2022 - 01/2005
17	Myocardial Infarction 01/2021 - 02/2003
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2004
15	Atrial Fibrillation 01/2021 - 04/2006
12	Inflammation (Inflammations) 01/2020 - 07/2008
11	ST Elevation Myocardial Infarction 05/2015 - 10/2008
10	Hypertension (High Blood Pressure) 10/2017 - 04/2006
8	Pulmonary Arterial Hypertension 01/2022 - 10/2007
8	Thrombosis (Thrombus) 03/2015 - 10/2006
7	Albuminuria 03/2016 - 03/2005
5	Stroke (Strokes) 09/2015 - 02/2003
4	Atherosclerosis 01/2020 - 01/2008
4	Weight Loss (Weight Reduction) 02/2016 - 05/2013
4	Infarction (Infarctions) 05/2015 - 01/2004
4	Type 2 Diabetes Mellitus (MODY) 04/2015 - 10/2005
4	Anemia 01/2015 - 09/2008
4	Systolic Heart Failure 12/2014 - 05/2011
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2011 - 07/2005
4	Renal Insufficiency (Renal Failure) 06/2005 - 10/2003
3	Disease Progression 01/2020 - 10/2012
3	Heart Diseases (Heart Disease) 01/2020 - 10/2008
3	Obesity 01/2017 - 09/2010
3	Chronic Renal Insufficiency 01/2014 - 12/2008
3	Fibrosis (Cirrhosis) 08/2013 - 05/2010
3	Insulin Resistance 12/2012 - 07/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 02/2008 - 07/2007
3	Coronary Disease (Coronary Heart Disease) 09/2006 - 01/2004
2	Down Syndrome (Down's Syndrome) 10/2020 - 09/2016
2	Diabetes Mellitus 10/2017 - 04/2007
2	Bacterial Infections (Bacterial Infection) 02/2016 - 09/2010
2	Sepsis (Septicemia) 02/2016 - 09/2010
2	Necrosis 08/2012 - 12/2011
2	Proteinuria 11/2006 - 02/2006
2	Peripheral Arterial Disease 01/2004 - 02/2003
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2020

Drug/Important Bio-Agent (IBA)

32	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2010
20	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 03/2006
14	CreatinineIBA 01/2021 - 02/2003
11	DiureticsIBA 02/2016 - 05/2011
10	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2005
10	C-Reactive ProteinIBA 02/2016 - 02/2003
9	Natriuretic PeptidesIBA 01/2018 - 01/2005
9	AlbuminsIBA 03/2016 - 10/2003
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2020 - 06/2005
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2006
6	rolofyllineIBA 01/2017 - 05/2013
6	Hemoglobins (Hemoglobin)IBA 02/2016 - 09/2008
5	Plasminogen Activator Inhibitor 1IBA 01/2018 - 10/2006
5	NitrogenIBA 01/2017 - 01/2014
5	Urea (Carbamide)FDA LinkGeneric 01/2017 - 01/2014
5	ReninIBA 05/2015 - 04/2006
5	Fosinopril (Monopril)FDA LinkGeneric 07/2008 - 11/2004
4	HDL CholesterolIBA 01/2018 - 09/2006
4	Galectin 3 (LGALS3)IBA 11/2017 - 05/2010
4	Erythropoietin FDA Link 01/2016 - 01/2007
4	Cystatin CIBA 01/2014 - 02/2012
4	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2011 - 10/2006
4	Pravastatin (Pravachol)FDA LinkGeneric 01/2008 - 11/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2013
3	ProcalcitoninIBA 01/2019 - 09/2010
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
3	Purinergic P1 Receptor AntagonistsIBA 01/2017 - 01/2014
3	Lipocalin-2IBA 01/2017 - 10/2008
3	Uric Acid (Urate)IBA 01/2017 - 01/2012
3	Furosemide (Lasix)FDA LinkGeneric 02/2016 - 05/2011
3	Antihypertensive Agents (Antihypertensives)IBA 01/2016 - 04/2012
3	ORALIT (ORS)IBA 09/2014 - 10/2005
3	Triglycerides (Triacylglycerol)IBA 12/2012 - 07/2005
3	LipidsIBA 04/2012 - 09/2006
3	Cholesterol Ester Transfer ProteinsIBA 07/2011 - 09/2006
2	ProstaglandinsIBA 01/2022 - 07/2010
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 08/2020 - 03/2015
2	HDL LipoproteinsIBA 01/2018 - 09/2006
2	PotassiumIBA 01/2018 - 01/2017
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018 - 07/2008
2	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 10/2017
2	TroponinIBA 01/2018 - 02/2008
2	SodiumIBA 10/2017 - 10/2013
2	Adenosine A1 ReceptorIBA 11/2016 - 05/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015 - 07/2005
2	Pharmaceutical PreparationsIBA 10/2015 - 11/2013
2	PeroxiredoxinsIBA 09/2014 - 10/2012
2	Digoxin (Digitek)FDA LinkGeneric 09/2014 - 04/2006
2	omega-Chloroacetophenone (Mace)IBA 04/2014 - 11/2010
2	Bosentan (Tracleer)FDA Link 02/2014 - 10/2007
2	Growth Differentiation Factor 15IBA 12/2013 - 08/2013
2	Epoetin Alfa (Epogen)FDA Link 10/2013 - 11/2010
2	Troponin T (Troponin T1)IBA 05/2013 - 09/2012
2	Advanced Glycation End ProductsIBA 11/2012 - 08/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2012 - 10/2005
2	CalciumIBA 02/2008 - 07/2007
2	Atrial Natriuretic Factor (ANF)IBA 04/2006 - 01/2005
1	Anti-Arrhythmia AgentsIBA 01/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 10/2020

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2005
11	Percutaneous Coronary Intervention 05/2015 - 10/2008
3	Patient Readmission 01/2017 - 05/2014
2	Heart Transplantation (Grafting, Heart) 05/2017 - 12/2014
2	Stents 09/2014 - 12/2011